[artículo] 
inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 512-517

Título :	C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients
Tipo de documento:	texto impreso
Autores:	Hui Hua Chang, Autor ; Po Wu Gean, Autor ; Chen Hsi Chou, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 512-517
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	GNB3, Valproato, Trastorno bipolar, Alteración metabólica, Leptina, IMC
Resumen:	Valproate (VPA) is a mood stabilizer for treating patients with bipolar disorder (BD). It may cause metabolic abnormalities in certain bipolar patients. However, the genetic factors that influence the susceptibility remain unclear. Genetic polymorphism of the G-protein β3 subunit (GNB3) is reported to be associated with metabolic phenotypes.
Link:	./index.php?lvl=notice_display&id=29423

[artículo] C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients [texto impreso] / Hui Hua Chang, Autor ; Po Wu Gean, Autor ; Chen Hsi Chou, Autor . - 2022 . - pp. 512-517.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 512-517

Palabras clave:	GNB3, Valproato, Trastorno bipolar, Alteración metabólica, Leptina, IMC
Resumen:	Valproate (VPA) is a mood stabilizer for treating patients with bipolar disorder (BD). It may cause metabolic abnormalities in certain bipolar patients. However, the genetic factors that influence the susceptibility remain unclear. Genetic polymorphism of the G-protein β3 subunit (GNB3) is reported to be associated with metabolic phenotypes.
Link:	./index.php?lvl=notice_display&id=29423